1. Academic Validation
  2. Gypsogenin derivatives: an unexpected class of inhibitors of cholinesterases

Gypsogenin derivatives: an unexpected class of inhibitors of cholinesterases

  • Arch Pharm (Weinheim). 2014 Oct;347(10):707-16. doi: 10.1002/ardp.201400103.
Lucie Heller 1 Stefan Schwarz Björn A Weber René Csuk
Affiliations

Affiliation

  • 1 Bereich Organische Chemie, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany.
Abstract

Gypsogenin (1) was obtained by acidic hydrolysis from its saponin. While the parent compound 1 acted as a selective inhibitor for butyrylcholinesterase (from equus) possessing a moderate mixed-type inhibition of the enzyme, Ki values as low as 2.67 ± 0.59 μM were determined for (3β,4α) 3-O-acetyl-olean-12-ene-23,28-dinitrile (11) and acetylcholinesterase (AChE, from electric eel). Thus, 11 possesses one-fifth of the inhibitory activity of the "gold standard" galantamine hydrobromide; this compound is one of the first Pentacyclic Triterpenoids described as a potent AChE-selective inhibitor.

Keywords

Acetylcholinesterase; Alzheimer's disease; Anticancer activity.

Figures
Products